Vatelizumab

Tax included
Vatelizumab (GBR500) is a monoclonal antibody targeting the α2 subunit (CD49b) of very late antigen-2 (VLA-2). Vatelizumab can be used for the research of multiple sclerosis.
MedChemExpress 
HY-P99524

Data sheet

Size
Multiple sizes
Reactivity
Others
CAS
1238217-55-4